X
Email:
sales@ruixibiotech.com

Liposomal nanoparticles encapsulating APG-115 and Lenvatinib,100nm

Liposome nanoparticles encapsulated APG-115(Alrizomadlin) and Lenvatinib, 100nm

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-Mcs-539 100mg 2509.00
- +
+ Add to cart
R-Mcs-539 250mg 5809.00
- +
+ Add to cart

Product description

Liposomal nanoparticles encapsulating APG-115 and Lenvatinib (liposome nanoparticles loaded with APG-115 and lenvatinib) are a dual drug co loaded targeted nanoformulation with a particle size controlled at approximately 100 nm, aimed at synergistically enhancing anti-tumor efficacy, particularly suitable for combination therapy of solid tumors such as liver cancer and thyroid adenocarcinoma.

This product is only for scientific research and cannot be used on the human body.

 

Liposomal nanoparticles encapsulating APG-115 and Lenvatinib,100nm

Appearance Freeze-dried powder
Size 100nm
Solubility N/A
Drug loading 4%(Lenvatinib); 4.5%(Alrizomadlin)
Encapsulation efficiency 92%(Lenvatinib); 96%(Alrizomadlin)
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 2 weeks
Stability 6 months
Document

Related Product